World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
26844
World Ranking
12771
National Ranking
6526

Overview

Dan Jones is affiliated with The Ohio State University in the United States. Their research spans primarily the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on Genetics, Oncology, Cancer Research, Pathology and Forensic Medicine, and Pulmonary and Respiratory Medicine as subfields of study.

The scientist's work covers several main topics, including:

  • Chronic Lymphocytic Leukemia Research
  • Cancer Genomics and Diagnostics
  • Lymphoma Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Acute Myeloid Leukemia Research
  • Pancreatitis Pathology and Treatment
  • Sarcoma Diagnosis and Treatment

Dan Jones has contributed to multiple publications, frequently publishing in the following venues:

  • Blood Advances
  • Modern Pathology
  • Blood
  • Hematological Oncology
  • Genes Chromosomes and Cancer

Their recent published papers include the following:

  • "Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative" (2021), published in JCO Precision Oncology
  • "Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial" (2020), published in Blood Advances
  • "Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients" (2020), published in Gynecologic Oncology
  • "Recent advances in the diagnostic evaluation of pancreatic cystic lesions" (2022), published in World Journal of Gastroenterology
  • "Electronic Health Records and Genomics" (2021), published in Journal of Molecular Diagnostics

Dan Jones collaborates frequently with several co-authors, including:

  • Weiqiang Zhao
  • Matthew R. Avenarius
  • Jennifer A. Woyach
  • Wendy L. Frankel
  • Somashekar G. Krishna

Best Publications

  • Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice

    Qing Ma;Dan Jones;Paul R. Borghesani;Rosalind A. Segal

  • Differentiation and reversal of malignant changes in colon cancer through PPARgamma.

    Pasha Sarraf;Elisabetta Mueller;Daniel Jones;Frederick J. King

  • The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment.

    Qing Ma;Dan Jones;Timothy A Springer

  • Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

    E. Jabbour;H. Kantarjian;D. Jones;M. Talpaz

  • BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.

    Jennifer A. Woyach;Amy S. Ruppert;Daphne Guinn;Amy Lehman

  • Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia

    Farhad Ravandi;Jorge E Cortes;Daniel Jones;Stefan H Faderl

  • Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia.

    Elihu Estey;Guillermo Garcia-Manero;Alessandra Ferrajoli;Stefan Faderl

  • MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation.

    Francis J. Giles;Jorge E Cortes;Dan Jones;Donald A Bergstrom

  • Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin

    Farhad Ravandi;Eli Estey;Dan Jones;Stefan Faderl

  • First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia

    Farhad Ravandi;Susan O'Brien;Deborah Thomas;Stefan Faderl

  • Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors.

    Jorge E Cortes;Elias Joseph Jabbour;Hagop M Kantarjian;Cheng Cameron Yin

  • Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors.

    Dan Jones;Lucy Lee;Juinn Lin Liu;Hsing-Jien Kung

  • Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate

    Jorge Cortes;Moshe Talpaz;Susan O'Brien;Dan Jones

  • Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia

    Jorge E. Cortes;Dan Jones;Susan O'Brien;Elias Jabbour

  • Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase

    Jorge E. Cortes;Dan Jones;Susan O'Brien;Elias Jabbour

  • Lenalidomide therapy in myelofibrosis with myeloid metaplasia.

    Ayalew Tefferi;Jorge E Cortes;Jorge E Cortes;Jorge E Cortes;Srdan Verstovsek;Srdan Verstovsek;Srdan Verstovsek;Ruben A. Mesa;Ruben A. Mesa;Ruben A. Mesa

  • Survival benefit with imatinib mesylate versus interferon-α–based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia

    Hagop M. Kantarjian;Moshe Talpaz;Susan O'Brien;Daniel Jones

  • Absence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in Peripheral Blood

    Dan Jones;Nam H. Dang;Madeleine Duvic;La Baron T. Washington

  • Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-α

    Hagop M. Kantarjian;Jorge E. Cortes;Susan O'Brien;Rajyalakshmi Luthra

  • Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy.

    Elias Jabbour;Hagop M. Kantarjian;Dan Jones;Jenny Shan

Frequent Co-Authors

Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Susan O'Brien
Susan O'Brien University of California, Irvine
L. Jeffrey Medeiros
L. Jeffrey Medeiros The University of Texas MD Anderson Cancer Center
Srdan Verstovsek
Srdan Verstovsek The University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero
Guillermo Garcia-Manero The University of Texas MD Anderson Cancer Center
Stefan Faderl
Stefan Faderl The University of Texas MD Anderson Cancer Center
Farhad Ravandi
Farhad Ravandi The University of Texas MD Anderson Cancer Center
Francis J. Giles
Francis J. Giles Northwestern University
Rajyalakshmi Luthra
Rajyalakshmi Luthra The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens up a diverse range of academic pathways, many of which can now be pursued online. For registered nurses aiming to advance their qualifications, programs like asn to fnp programs offer a streamlined route from an associate degree to becoming a Family Nurse Practitioner—greatly expanding career options.

Interested in preventative healthcare? Pursuing an online nutritionist degree can equip you with the skills needed to guide patients on healthy eating and wellness, a vital aspect of modern healthcare.

Accreditation is critical when choosing an online program. Prospective leaders should consider which online healthcare degree programs are recognized for their accreditation by cahme? to ensure a strong reputation and transferability of their qualifications.

For working nurses, flexibility is important. There are also options for rn to bsn online programs without clinicals, which allow professionals to advance their education without the need for on-site clinical work.

These online degrees offer accessible pathways to specialized roles within the U.S. healthcare system, supporting a broad range of interests and career goals.

Best Scientists Citing Dan Jones

Trending Scientists

Recently Published Articles